Important: The following data is for information purposes only. Please note that access to VAC drug benefits will vary depending upon an individual's eligibility and specific health needs. More Details
This information was posted August 29, 2012. Additions or revisions to the Formulary may have subsequently occurred.
Displaying 19411 - 19420 of 24215
| Identification Number | Trade Name | Benefit Category |
|---|---|---|
| 02457210 | MED-DORZOLAMIDE OPH LIQ SOL 2% | Standard Benefit for Eligible Clients |
| 02457229 | APO-QUETIAPINE XR EXTENDED RELEASE TAB 50MG | Standard Benefit for Eligible Clients |
| 02457237 | APO-QUETIAPINE XR EXTENDED RELEASE TAB 150MG | Standard Benefit for Eligible Clients |
| 02457245 | APO-QUETIAPINE XR EXTENDED RELEASE TAB 200MG | Standard Benefit for Eligible Clients |
| 02457253 | APO-QUETIAPINE XR EXTENDED RELEASE TAB 300MG | Standard Benefit for Eligible Clients |
| 02457261 | APO-QUETIAPINE XR EXTENDED RELEASE TAB 400MG | Standard Benefit for Eligible Clients |
| 02457288 | SANDOZ AMPHETAMINE XR CAP 5MG | Standard Benefit for Eligible Clients |
| 02457296 | SANDOZ AMPHETAMINE XR CAP 10MG | Standard Benefit for Eligible Clients |
| 02457318 | SANDOZ AMPHETAMINE XR CAP 15MG | Standard Benefit for Eligible Clients |
| 02457326 | SANDOZ AMPHETAMINE XR CAP 20MG | Standard Benefit for Eligible Clients |
Displaying 19411 - 19420 of 24215